Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a462a46d603452762c1968999cc2c28 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
filingDate |
2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8cb78113b15f61865623943cdb0704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab176d339a9cda121ef7a8d609f1ebe5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446450104acd92caf634bc55670aef96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aae279a7742cde6687ecac95c6b2bd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a13988507c3bab0108b559b35d2c74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470d495c7d0b9dc4744ce673160ec7f7 |
publicationDate |
2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114173775-A |
titleOfInvention |
Pharmaceutical composition of parsnipide and use thereof |
abstract |
A pharmaceutical composition for antiviral treatment of mammalian papillomavirus-related diseases, comprising a therapeutically effective amount of parsnipide or a parsnipide-related substance or an enriched plant comprising parsnip acid and parsnipide Extract. The pharmaceutical composition may be contained in an oil-in-water emulsion, for example in a homogeneous mixture of at least one oil and at least one surfactant, or alternatively in a hydrophilic solvent and a cosolvent or surfactant or a combination thereof Parsnipides or Parsnipides-related substances or enriched extracts in . Also provided are methods of treating or preventing papillomavirus-related diseases in mammals. |
priorityDate |
2019-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |